$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 29.22 | 35,933 | 1,049,880 | 327,391 | 363.3 K to 327.4 K (-9.89 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 28.34 | 17,457 | 494,695 | 363,324 | 380.8 K to 363.3 K (-4.58 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 27.23 | 22,161 | 603,511 | 380,781 | 402.9 K to 380.8 K (-5.50 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 7.10 | 195,831 | 1,390,400 | 402,942 | 207.1 K to 402.9 K (+94.55 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 6.90 | 44,180 | 304,842 | 207,111 | 162.9 K to 207.1 K (+27.12 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 6.30 | 71,614 | 451,168 | 162,931 | 91.3 K to 162.9 K (+78.42 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 14.28 | 70,000 | 999,600 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 14.31 | 123,156 | 1,762,362 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 10.27 | 24,348 | 250,054 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.90 | 48,697 | 336,009 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.30 | 64,323 | 405,235 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 36.74 | 300 | 11,022 | 35,441 | 35.7 K to 35.4 K (-0.84 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 35.46 | 2,800 | 99,282 | 35,741 | 38.5 K to 35.7 K (-7.26 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 34.68 | 103,826 | 3,600,603 | 38,541 | 142.4 K to 38.5 K (-72.93 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 33.81 | 30,284 | 1,023,793 | 142,367 | 172.7 K to 142.4 K (-17.54 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 32.57 | 15,686 | 510,887 | 172,651 | 188.3 K to 172.7 K (-8.33 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 31.70 | 33,883 | 1,074,094 | 188,337 | 222.2 K to 188.3 K (-15.25 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 30.77 | 75,868 | 2,334,618 | 222,220 | 298.1 K to 222.2 K (-25.45 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 29.25 | 31,559 | 922,952 | 298,088 | 329.6 K to 298.1 K (-9.57 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 28.45 | 14,484 | 412,012 | 329,647 | 344.1 K to 329.6 K (-4.21 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 27.29 | 21,834 | 595,904 | 344,131 | 366 K to 344.1 K (-5.97 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 14.28 | 70,000 | 999,600 | 365,965 | 296 K to 366 K (+23.65 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 14.31 | 123,156 | 1,762,362 | 295,965 | 172.8 K to 296 K (+71.27 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 10.27 | 24,348 | 250,054 | 172,809 | 148.5 K to 172.8 K (+16.40 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.90 | 48,697 | 336,009 | 148,461 | 99.8 K to 148.5 K (+48.81 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.30 | 64,323 | 405,235 | 99,764 | 35.4 K to 99.8 K (+181.49 %) |
Nov 05 2019 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | A | 9.04 | 40,000 | 361,600 | 40,000 | |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 7.74 | 17,907 | 138,600 | 91,317 | 109.2 K to 91.3 K (-16.39 %) |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 33,334 | 0 | 109,224 | 75.9 K to 109.2 K (+43.92 %) |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 7.74 | 17,907 | 138,600 | 91,317 | 109.2 K to 91.3 K (-16.39 %) |
Oct 22 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 33,334 | 0 | 109,224 | 75.9 K to 109.2 K (+43.92 %) |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 18,010 | 108,060 | 31,990 | |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Sell | S | 12.00 | 12,815 | 153,806 | 72,199 | 85 K to 72.2 K (-15.07 %) |
Jun 03 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 18,010 | 108,060 | 85,014 | 67 K to 85 K (+26.88 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Grant | A | 0.00 | 7,724 | 0 | 98,241 | 90.5 K to 98.2 K (+8.53 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Grant | A | 0.00 | 7,724 | 0 | 7,724 | 0 to 7.7 K |
May 23 2019 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 7,724 | 0 | 60,363 | 52.6 K to 60.4 K (+14.67 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | MCKINNELL HENRY A | Director | Buy | M | 0.00 | 8,421 | 0 | 52,639 | 44.2 K to 52.6 K (+19.04 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 0.00 | 8,421 | 0 | 67,004 | 58.6 K to 67 K (+14.37 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 8,421 | 0 | 35,345 | 26.9 K to 35.3 K (+31.28 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Grant | A | 0.00 | 7,724 | 0 | 161,697 | 154 K to 161.7 K (+5.02 %) |
Apr 17 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 2.10 | 33,000 | 69,300 | 147,000 | |
Apr 17 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Sell | S | 12.96 | 33,000 | 427,706 | 10,614 | 43.6 K to 10.6 K (-75.66 %) |
Apr 17 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 2.10 | 33,000 | 69,300 | 43,614 | 10.6 K to 43.6 K (+310.91 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 74,986 | 449,916 | 0 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 79,259 | 475,554 | 74,986 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 5,755 | 34,530 | 154,245 | |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.85 | 74,986 | 1,038,909 | 2,228,855 | 2.3 M to 2.2 M (-3.25 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 74,986 | 449,916 | 2,303,841 | 2.2 M to 2.3 M (+3.36 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.58 | 79,259 | 1,076,084 | 2,228,855 | 2.3 M to 2.2 M (-3.43 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 79,259 | 475,554 | 2,308,114 | 2.2 M to 2.3 M (+3.56 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 5,755 | 80,570 | 2,228,855 | 2.2 M to 2.2 M (-0.26 %) |
Apr 02 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 5,755 | 34,530 | 2,234,610 | 2.2 M to 2.2 M (+0.26 %) |
Mar 29 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 35,000 | 124,950 | 106,963 | |
Mar 29 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 13.05 | 35,000 | 456,827 | 75,890 | 110.9 K to 75.9 K (-31.56 %) |
Mar 29 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 35,000 | 124,950 | 110,890 | 75.9 K to 110.9 K (+46.12 %) |
Mar 29 2019 | CCXI | ChemoCentryx, Inc. | Jain Rita | Director | Option Exercise | A | 0.00 | 15,753 | 0 | 15,753 | |
Mar 08 2019 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
Mar 08 2019 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Buy | M | 0.00 | 8,421 | 0 | 102,267 | 93.8 K to 102.3 K (+8.97 %) |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | A | 11.02 | 33,333 | 367,330 | 33,333 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 11.02 | 230,000 | 2,534,600 | 230,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 70,000 | 0 | 70,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 11.02 | 80,000 | 881,600 | 80,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 11.02 | 70,000 | 771,400 | 70,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Mar 06 2019 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | A | 11.02 | 54,000 | 595,080 | 54,000 | |
Feb 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 3,037 | 10,842 | 141,963 | |
Feb 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 3,037 | 10,842 | 75,890 | 72.9 K to 75.9 K (+4.17 %) |
Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 37,893 | 135,278 | 145,000 | |
Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 12.08 | 37,893 | 457,747 | 72,853 | 110.7 K to 72.9 K (-34.22 %) |
Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 37,893 | 135,278 | 110,746 | 72.9 K to 110.7 K (+52.01 %) |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 36,762 | 220,572 | 160,000 | |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.16 | 36,762 | 447,092 | 2,228,855 | 2.3 M to 2.2 M (-1.62 %) |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 36,762 | 220,572 | 2,265,617 | 2.2 M to 2.3 M (+1.65 %) |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 6,172 | 37,032 | 0 | |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.00 | 6,172 | 74,079 | 35,441 | 41.6 K to 35.4 K (-14.83 %) |
Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 6,172 | 37,032 | 41,613 | 35.4 K to 41.6 K (+17.41 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 12,895 | 77,370 | 196,762 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 7,275 | 43,650 | 209,657 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 12,895 | 154,771 | 2,228,855 | 2.2 M to 2.2 M (-0.58 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 12,895 | 77,370 | 2,241,750 | 2.2 M to 2.2 M (+0.58 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.04 | 7,275 | 87,599 | 2,228,855 | 2.2 M to 2.2 M (-0.33 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 7,275 | 43,650 | 2,236,130 | 2.2 M to 2.2 M (+0.33 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 8,134 | 48,804 | 6,172 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 5,069 | 30,414 | 14,306 | |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.00 | 8,134 | 97,628 | 35,441 | 43.6 K to 35.4 K (-18.67 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 8,134 | 48,804 | 43,575 | 35.4 K to 43.6 K (+22.95 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.07 | 5,069 | 61,162 | 35,441 | 40.5 K to 35.4 K (-12.51 %) |
Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 5,069 | 30,414 | 40,510 | 35.4 K to 40.5 K (+14.30 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 60,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 10.91 | 52,806 | 576,113 | 2,228,855 | 2.3 M to 2.2 M (-2.31 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,281,661 | 2.3 M to 2.3 M (+1.33 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,251,661 | 2.2 M to 2.3 M (+1.50 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,334 | 0 | 2,218,328 | 2.2 M to 2.2 M (+1.53 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 13,333 | 0 | 13,334 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 10.91 | 24,008 | 261,927 | 72,853 | 96.9 K to 72.9 K (-24.79 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 96,861 | 86.9 K to 96.9 K (+11.51 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 13,333 | 0 | 86,861 | 73.5 K to 86.9 K (+18.13 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 20,000 | 0 | 73,528 | 53.5 K to 73.5 K (+37.36 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Payment of Exercise | F | 10.91 | 8,716 | 95,092 | 10,614 | 19.3 K to 10.6 K (-45.09 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 0.00 | 5,000 | 0 | 19,330 | 14.3 K to 19.3 K (+34.89 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 0.00 | 10,000 | 0 | 14,330 | 4.3 K to 14.3 K (+230.95 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 8,334 | 0 | 0 | |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 10.91 | 13,385 | 146,030 | 35,441 | 48.8 K to 35.4 K (-27.41 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,666 | 0 | 48,826 | 42.2 K to 48.8 K (+15.81 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 10,000 | 0 | 42,160 | 32.2 K to 42.2 K (+31.09 %) |
Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 8,334 | 0 | 32,160 | 23.8 K to 32.2 K (+34.98 %) |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 7,211 | 43,266 | 216,932 | |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 7,211 | 86,554 | 2,184,994 | 2.2 M to 2.2 M (-0.33 %) |
Nov 09 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 7,211 | 43,266 | 2,192,205 | 2.2 M to 2.2 M (+0.33 %) |
Oct 30 2018 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 30,237 | 181,422 | 19,375 | |
Oct 30 2018 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.01 | 30,237 | 332,779 | 23,826 | 54.1 K to 23.8 K (-55.93 %) |
Oct 30 2018 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 30,237 | 181,422 | 54,063 | 23.8 K to 54.1 K (+126.91 %) |
Oct 23 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
Oct 23 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 11.41 | 17,940 | 204,695 | 53,528 | 71.5 K to 53.5 K (-25.10 %) |
Oct 23 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 33,333 | 0 | 71,468 | 38.1 K to 71.5 K (+87.41 %) |
Oct 18 2018 | CCXI | ChemoCentryx, Inc. | GLAXOSMITHKLINE PLC | Sell | S | 11.69 | 7,343,492 | 85,845,421 | 0 | 7.3 M to 0 (-100.00 %) | |
Jul 31 2018 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Option Exercise | M | 0.00 | 6,767 | 0 | 0 | |
Jul 31 2018 | CCXI | ChemoCentryx, Inc. | Edwards Thomas A. | Director | Buy | M | 0.00 | 6,767 | 0 | 153,973 | 147.2 K to 154 K (+4.60 %) |
Jul 03 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 100 | 357 | 182,893 | |
Jul 03 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 14.10 | 100 | 1,410 | 38,135 | 38.2 K to 38.1 K (-0.26 %) |
Jul 03 2018 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 100 | 357 | 38,235 | 38.1 K to 38.2 K (+0.26 %) |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 100 | 600 | 224,143 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 100 | 600 | 224,143 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 10,757 | 64,542 | 224,243 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 10,757 | 64,542 | 224,243 | |
Jul 02 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.10 | 100 | 1,410 | 2,184,994 | 2.2 M to 2.2 M (0.00 %) |